GlaxoSmithKline Kenya Transitions to Haleon Kenya Limited
GlaxoSmithKline Limited (GSK) in Kenya has officially changed its legal entity name to Haleon Kenya Limited, effective March 14, 2025. This rebranding marks a significant transition in the company’s operations within the region.
Background of Haleon Formation
Haleon emerged as an independent consumer health company on July 18, 2022, following its demerger from GSK. The company houses trusted brands such as Sensodyne, Panadol, Eno, and Scott’s Emulsion—products relied upon by millions globally to improve everyday health.
Commitment to Innovation and Local Manufacturing
Mark Pfister, Haleon’s General Manager for Sub-Saharan Africa, emphasized that the transition signifies more than a name change. It reaffirms the company’s dedication to delivering high-quality, science-led health solutions tailored for Kenyan consumers. Haleon plans to enhance its focus on innovation by developing products that combine trusted science with deep human understanding to meet the evolving healthcare needs of Kenyans. Additionally, the company is expanding its local manufacturing capabilities to ensure greater accessibility to essential health products while maintaining the highest quality standards.
Operations and Regional Presence
Haleon Kenya Limited operates a state-of-the-art production facility on Likoni Road, Nairobi. This site plays a crucial role in the country’s oral healthcare and pain relief landscape, producing millions of units annually of leading brands such as Sensodyne, Aquafresh, and Panadol. Beyond meeting local demand, the facility serves as a regional hub, exporting to seven East African markets and South Africa.
Packaging Transition and Consumer Assurance
As the company transitions from GSK to Haleon, product packaging will gradually evolve—from featuring the GSK logo to no logo, and eventually to the Haleon logo. Consumers may notice branding differences across various assets or even among different packages of the same product on shelves. Despite these temporary variations, Haleon assures that its commitment to delivering the highest standards of quality remains unchanged. Importantly, this legal name change will not impact daily operations, product manufacturing, or staffing.
Sustainability Initiatives
In 2024, Haleon Kenya Limited achieved Net Carbon Zero (NCZ) certification. Earlier this year, it also received Alliance for Water Stewardship and True Waste certifications, reinforcing its commitment to sustainable operations and environmental stewardship. A significant step in this sustainability journey is the company’s investment in solar energy. The Likoni Road facility is powered by solar panels, reducing reliance on non-renewable energy sources and significantly lowering its carbon footprint.
Haleon aims to empower Kenyans to take control of their health through self-care. By combining trusted science with deep human understanding, the company strives to deliver quality health solutions, ease the burden on Kenya’s healthcare system, and shape a healthier future for all.
